<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[아스트로젠 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=35492></link><description><![CDATA[아스트로젠 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Fri, 19 Jun 2026 13:46:40 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2020/07/12_3067119027_20200710155527_2835402357.png]]></url></image><language>ko-KR</language><item><title><![CDATA[Astrogen Inc. Validates Autism Spectrum Disorder Research with Prestigious Folia Award]]></title><link>https://www.newswire.co.kr/newsRead.php?no=1036970</link><description><![CDATA[YOKOHAMA, Japan--(Korea Newswire)--Astrogen, Inc. , a leading biotech company in South Korea, said that it has received the “Folia Award  (ISSN)1440-1819.folia-awards)” granted by the international psychiatric journal Psychiatry and Clinical Neurosciences  (PCN) for its ASD clinical trial paper.  The Folia Award is given annually to the most outstanding paper published in PCN, th...]]></description><pubDate>Fri, 19 Jun 2026 11:01:22 +0900</pubDate></item></channel></rss>